A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)

Clinical trial NCT06514794 · RECRUITING

Trial details

NCT number: NCT06514794
Sponsor: Allotera Therapeutics
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

T-cell Acute Lymphoblastic Leukemia Lymphoblastic Lymphoma

Start date: 2025-01-31
Primary completion: 2026-12-30
Enrollment: 125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.